| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2004 | US6763607 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 07/20/2004 | CA2408633C Management of snoring by oral administration of dimethyl sulfone |
| 07/20/2004 | CA2396927C Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 07/20/2004 | CA2346320C Aqueous-centre microcapsules containing at least one water-soluble, cosmetic or dermatological active ingredient and cosmetic or dermatological compositions containing them |
| 07/20/2004 | CA2292388C Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 07/20/2004 | CA2286733C Reverse-turn mimetics and methods relating thereto |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 07/20/2004 | CA2254795C Novel method for isomerising the 10-methyl radical of erythromycin derivatives |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2231194C Pharmaceutical formulation |
| 07/20/2004 | CA2216634C Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc |
| 07/20/2004 | CA2175368C Proliferation antagonistic inhibitor of mesenchymal cells |
| 07/20/2004 | CA2134972C Anti-ischemic medicament |
| 07/20/2004 | CA2094122C Direct compression method for preparing pills having cephalosporanic acid derivatives |
| 07/20/2004 | CA2085555C Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
| 07/20/2004 | CA2079703C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |
| 07/20/2004 | CA2079482C Antiviral compositions and method for their use |
| 07/20/2004 | CA2075904C Method of treating pre-menstrual syndrome |
| 07/17/2004 | CA2416799A1 Pharmaceutical compositions and methods for treating multidrug resistant cancer |
| 07/15/2004 | WO2004058817A1 Novel proteins and use thereof |
| 07/15/2004 | WO2004058796A1 Promoter for the production of hyaluronic acid containing ginsenoside compound k |
| 07/15/2004 | WO2004058795A1 Angiogenic compounds and uses thereof |
| 07/15/2004 | WO2004058791A2 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 07/15/2004 | WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | WO2004058788A1 Lipid a analogues having glucose as the right sugar |
| 07/15/2004 | WO2004058782A1 Therapeutic quinazoline derivatives |
| 07/15/2004 | WO2004058781A1 Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| 07/15/2004 | WO2004058770A1 Triptolide derivatives and their use |
| 07/15/2004 | WO2004058769A2 Triazolopyridazines as protein kinases inhibitors |
| 07/15/2004 | WO2004058767A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 07/15/2004 | WO2004058763A1 4(spiropiperidinyl)methyl substituted pyrrolidines as modulators of chemokine receptor activity |
| 07/15/2004 | WO2004058762A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds |
| 07/15/2004 | WO2004058761A1 Pyrazole compounds as integrin receptor antagonists derivatives |
| 07/15/2004 | WO2004058757A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 07/15/2004 | WO2004058756A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 07/15/2004 | WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
| 07/15/2004 | WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity |
| 07/15/2004 | WO2004058753A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase |
| 07/15/2004 | WO2004058752A1 Quinazoline compounds |
| 07/15/2004 | WO2004058749A1 Benzisoxazole derivatives useful as inhibitors of protein kinases |
| 07/15/2004 | WO2004058747A1 Fc receptor modulating compounds and compositions |
| 07/15/2004 | WO2004058746A1 Substituted benzodioxepins |
| 07/15/2004 | WO2004058745A1 Optically active dihydropyridine derivative |
| 07/15/2004 | WO2004058742A1 Benzocycloheptapyridine compounds |
| 07/15/2004 | WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/15/2004 | WO2004058738A1 Total synthesis of daurichromenic acid |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/15/2004 | WO2004058721A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 07/15/2004 | WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
| 07/15/2004 | WO2004058713A1 Differential tumor cytotoxocity compounds and compositions |
| 07/15/2004 | WO2004058704A2 Quinazolinones as potassium channel modulators |
| 07/15/2004 | WO2004058697A1 4-nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivates and their pharmaceutical use |
| 07/15/2004 | WO2004058691A1 Antifungal antibiotics |
| 07/15/2004 | WO2004058679A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004058354A1 Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive event |
| 07/15/2004 | WO2004058353A2 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 07/15/2004 | WO2004058343A1 Soft filament occlusive device delivery system |
| 07/15/2004 | WO2004058329A2 Ester combination local anesthetic |
| 07/15/2004 | WO2004058304A1 Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection |
| 07/15/2004 | WO2004058303A2 Compositions of benzoquinolizine carboxylic acid antibiotic drugs |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058301A1 Composition for improving swallowing reflex failure |
| 07/15/2004 | WO2004058293A1 Methods of diagnosing, preventing, and treating early onset of pulmonary hypertension |
| 07/15/2004 | WO2004058289A1 Ophthalmic formulation for the prevention and treatment of ocular conditions |
| 07/15/2004 | WO2004058286A1 Administration of capsaicinoids |
| 07/15/2004 | WO2004058281A1 Cholesterol-reducing agent containing an n-3 fatty acid |
| 07/15/2004 | WO2004058279A1 Composition comprising scutellaria baicalensis and their uses thereof |
| 07/15/2004 | WO2004058277A1 Biocompatible dialysis fluids containing icodextrins |
| 07/15/2004 | WO2004058276A1 Histamine release inhibitor |
| 07/15/2004 | WO2004058274A1 Method of treating patients exposed to toxic chemical agents |
| 07/15/2004 | WO2004058273A1 Use of rimexolone in the treatment of dry eye |
| 07/15/2004 | WO2004058272A1 Steroid compositions for intraocular use |
| 07/15/2004 | WO2004058271A1 Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| 07/15/2004 | WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases |
| 07/15/2004 | WO2004058269A1 Use of gnrh agonists to support the luteal phase during infertility treatment |
| 07/15/2004 | WO2004058268A2 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders |
| 07/15/2004 | WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors |
| 07/15/2004 | WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor |
| 07/15/2004 | WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor |
| 07/15/2004 | WO2004058262A1 Benzoquinolizine-2-carboxylic acid-containing compositions |
| 07/15/2004 | WO2004058261A1 Antibacterial water-based preparation |
| 07/15/2004 | WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors |
| 07/15/2004 | WO2004058258A1 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 07/15/2004 | WO2004058257A1 Controlled release formulation comprising benzimidazole derivatives or pharmaceutically acceptable salts thereof with increased stability and method for preparing the same |
| 07/15/2004 | WO2004058256A1 Pharmaceutical liquid composition containing pyridone derivative |
| 07/15/2004 | WO2004058254A1 Heteroarylalkanoic acids as integrin receptor antagonists |
| 07/15/2004 | WO2004058253A1 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 07/15/2004 | WO2004058252A2 Anti-cancer agents comprising alkb inhibitors and alkylating agents |
| 07/15/2004 | WO2004058251A1 Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators |
| 07/15/2004 | WO2004058250A1 Bone regeneration product for human and veterinary use, containing melatonin as active principle |
| 07/15/2004 | WO2004058249A1 1,5-diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators |
| 07/15/2004 | WO2004058248A1 Medicaments containing substituted 2,5-diaminomethyl-1h-pyrroles |
| 07/15/2004 | WO2004058247A1 Device for the transdermal administration of a rotigotine base |
| 07/15/2004 | WO2004058245A1 Tanshinone iia for prophylaxising or treating atherosclerosis |
| 07/15/2004 | WO2004058244A1 The use of succinate derivative esters for the treatment of dementia |
| 07/15/2004 | WO2004058243A1 Inhibitor for liver cancer onset and progress |
| 07/15/2004 | WO2004058242A1 Nutritional composition for oral use |
| 07/15/2004 | WO2004058241A1 Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (paba) |
| 07/15/2004 | WO2004058240A1 Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |